Explore the heart's electrical system and the three mechanisms that cause supraventricular tachycardia—reentry, enhanced automaticity, and triggered activity—along with the three main SVT subtypes. Learn diagnostic approaches from EKGs to electrophysiology studies, and understand every treatment option from vagal manoeuvres and medications to catheter ablation.
If you have recently been diagnosed with supraventricular tachycardia — or if someone you love has — you may have left your doctor's office with a name for what has been happening, but not much of an explanation for why it happens, what it means for your life, or what can be done about it in any depth. This course exists to fix that. By the time you finish it, you will understand your heart's electrical system, the precise mechanism causing your episodes, every diagnostic tool your doctor might use, and every treatment option on the table — in enough detail to ask sharp questions and make genuinely informed decisions.
Let's begin with the big picture.
The full name is supraventricular tachycardia, which combines three Latin and Greek roots: supra (above), ventricular (relating to the ventricles, the heart's lower pumping chambers), and tachycardia (fast heart). Put it together and SVT means: a fast heart rhythm that originates above the ventricles. The reason that anatomical distinction matters so much will become clear as you learn more, but in brief — fast rhythms that originate in the lower chambers are a different and more dangerous category. SVT is not that.
SVT is actually a family of related conditions rather than a single disease. What the members of this family share is that they all produce episodes of rapid heart rate — typically between 150 and 250 beats per minute — that begin suddenly, maintain a steady fast rate, and end suddenly, often as though a switch has been flipped. These episodes are called paroxysms (from the Greek for a sudden attack), which is why SVT is sometimes described as paroxysmal SVT, or PSVT.
SVT is one of the most common sustained cardiac arrhythmias seen in clinical practice, with an estimated prevalence of roughly 2.25 per 1,000 people. It affects people of all ages, including young adults, children, and otherwise completely healthy individuals. This last point is important: SVT typically occurs in structurally normal hearts. There is usually nothing wrong with the heart muscle itself. The issue is electrical — a quirk in the wiring, not a weakness in the pump.
All SVTs are produced by one of three fundamental electrical mechanisms.
The most common by far — responsible for the vast majority of SVT cases — is called reentry. In reentry, an electrical impulse finds a way to loop back through tissue it has already activated, establishing a self-sustaining circuit that drives the heart faster than the normal pacemaker would. Think of it as a rogue electrical loop that, once started, keeps feeding itself. Understanding reentry in detail is one of the most important things you will do in this course, because it explains not just why SVT happens, but why specific treatments work.
The second mechanism is enhanced automaticity, in which a group of heart cells outside the normal pacemaker begins firing spontaneously at an abnormally fast rate. The third is triggered activity, in which abnormal electrical oscillations following a normal heartbeat can ignite an extra beat or a run of fast beats. These two mechanisms are less common than reentry but important to understand because they explain certain SVT subtypes that behave differently and respond differently to treatment.
Within the SVT family, three subtypes account for the vast majority of cases, and understanding them individually is one of the central goals of this course.
AVNRT (AV nodal reentrant tachycardia) is the most common, making up roughly 50–60% of all SVT. It involves a tiny reentrant circuit within and immediately around the AV node — a critical electrical relay station between the upper and lower chambers of the heart. A subtle anatomical feature, present in many people, creates two distinct electrical pathways in this region, and under the right circumstances they can form a self-sustaining loop.
AVRT (AV reentrant tachycardia) accounts for around 30% of SVT cases. It involves an extra strand of conductive tissue — called an accessory pathway — that some people are born with. This extra pathway bypasses the normal electrical gateway between the upper and lower chambers, and the reentrant circuit uses both this bypass and the normal conduction system, creating a larger loop. When this accessory pathway is visible on a resting electrocardiogram, the condition is called Wolff-Parkinson-White syndrome — a diagnosis that carries some additional considerations you will fully understand by the end of the course.
Atrial tachycardia (AT) accounts for most of the remaining cases. Unlike the first two subtypes, AT originates entirely within the atrial muscle itself, independent of the AV node, and its behavior and treatment differ in important ways.
The experience of an SVT episode varies from person to person, but the most universal feature is a sudden, rapid, regular pounding of the heart — palpitations that feel like the heart is racing, hammering, or fluttering. Many people describe the onset as a sudden lurch or flip followed immediately by the fast rhythm. Some people feel dizzy or lightheaded because the heart is beating too fast to fill adequately between beats. Breathlessness, chest tightness, and a pounding sensation in the neck or throat are also common. Some people feel extremely anxious during episodes, partly from the physical sensations and partly because a racing heart is inherently alarming.
Episodes can last seconds, minutes, or hours. They end spontaneously or, in some cases, require treatment to stop. After a long episode, some people notice a strong urge to urinate — this is a real and well-explained phenomenon caused by hormones released during rapid atrial contraction, and you will understand exactly why it happens.
It is worth saying clearly: SVT does not shorten life expectancy in the vast majority of people. It is not a sign of a diseased heart muscle. But it can significantly affect quality of life, and that is a very legitimate reason to understand and treat it.
Because SVT episodes are intermittent and often brief, diagnosis can require some detective work. The gold standard is capturing the abnormal rhythm on an electrocardiogram (EKG) — a recording of the heart's electrical activity — during an actual episode. When that is not possible during a clinic visit, doctors use ambulatory monitors that you wear at home: a Holter monitor for continuous recording over days, or an event recorder that you activate yourself when symptoms strike.
For the most precise diagnosis — especially when ablation (a curative procedure) is being considered — an electrophysiology (EP) study is performed. This is a procedure in which thin, flexible electrode catheters are guided into the heart to map its electrical activity in precise detail, deliberately provoke the SVT under controlled conditions, and pinpoint exactly where the abnormal circuit or focus is. The EP study is also the platform from which treatment by catheter ablation is delivered.
Treatment for SVT ranges from simple manoeuvres you can do yourself to a highly effective curative procedure.
Vagal manoeuvres — including the Valsalva manoeuvre, in which you bear down as though having a bowel movement, or the modified Valsalva — can terminate an episode by stimulating the body's natural braking system for the heart. They work often enough to be the first thing anyone should try.
Adenosine is a medication given intravenously in emergency settings that temporarily blocks the AV node's ability to conduct electricity, which breaks the reentrant loop in most SVT cases. It works in seconds, produces an intensely unpleasant but brief sensation, and is highly effective.
Long-term medications — including beta blockers, calcium channel blockers, and antiarrhythmic drugs — can reduce the frequency and severity of episodes for patients who prefer to manage SVT medically rather than pursue a definitive procedure.
Catheter ablation is the closest thing to a cure that exists for SVT. In this procedure, catheters are used to deliver precisely targeted energy (usually radiofrequency heat, sometimes extreme cold) to destroy the tiny piece of tissue responsible for the abnormal circuit. Success rates are high — above 95% for the most common SVT subtype — and the procedure is performed under sedation, usually with a same-day or next-morning discharge. Understanding ablation in full detail, including what happens step by step and what the real risks are, is one of the most important things this course will give you.
Watchful waiting — choosing not to treat and simply learning to live with occasional episodes — is a legitimate choice for people whose episodes are infrequent, brief, and not significantly affecting their lives. This is a real option, not a last resort, and you deserve to understand what it actually means to live with unablated SVT.
This course is built in five domains, each of which adds a layer of understanding.
You will start with the heart itself — its chambers, valves, and the intricate electrical system that drives every heartbeat. You will learn what each part does and why it matters for understanding SVT. Then you will move into SVT as a condition — what makes a rhythm supraventricular, how the three electrical mechanisms work, and what happens during an episode at a cellular and circuit level. After that, you will examine each of the three main SVT subtypes in depth. Then symptoms, triggers, and every diagnostic tool will be covered. Finally, you will work through the complete treatment landscape in enough detail that no treatment recommendation will feel opaque or arbitrary.
The goal throughout is not to make you a cardiologist. The goal is to make you a fully informed participant in your own care — someone who understands what is happening, why, and what every option means. That kind of understanding does not produce anxiety. It replaces anxiety with clarity.
SVT is a condition that medicine understands exceptionally well. It is highly treatable. And it is far less frightening once you truly know what it is.